The iconic rise of Viagra has consistently remained a example of pharmaceutical success, yet its position within the broader industry now raises questions about long-term gains. Alternative versions are diminishing exclusivity , causing worries that investing in companies closely tied to Viagra's once-dominant standing could be a problematic decisi